Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants

Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants

Bibliographic Details
Main Authors: Bosco Paes, Marcello Lanari, Barry Rodgers-Gray, John Fullarton, Xavier Carbonell-Estrany
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Pediatrics
Subjects:
respiratory syncytial virus
risk factors
pediatric hospitalization
passive immunoprophylaxis
preterm infants
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2024.1343960/full
Description
ISSN:2296-2360

Similar Items